Novel targets to overcome antiangiogenesis therapy resistance in glioblastoma multiforme: Systems biology approach and suggestion of therapy by galunisertib
Sign Up to like & getrecommendations! Published in 2022 at "Cell Biology International"
DOI: 10.1002/cbin.11859
Abstract: Glioblastoma multiforme (GBM) is a tumor with high microvessel density. Antiangiogenesis therapy (AAT) resistance occurs due to the complex mechanisms involved in angiogenesis, with increased chances of recurrence. The vascular endothelial growth factor (VEGF) pathway… read more here.
Keywords: therapy; resistance; antiangiogenesis therapy; glioblastoma multiforme ... See more keywords
Antiangiogenic Therapy in Gastroesophageal Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2017.01.008
Abstract: Antiangiogenesis therapy is one of only 2 biologically targeted approaches shown to improve overall survival over standard of care in advanced adenocarcinoma of the stomach or gastroesophageal junction (GEJ). Therapeutic targeting of vascular endothelial growth… read more here.
Keywords: antiangiogenic therapy; therapy gastroesophageal; cancer; therapy ... See more keywords